Toggle Main Menu Toggle Search

Open Access padlockePrints

Management of the Urologic Sepsis Syndrome

Lookup NU author(s): Dr Zafer Tandogdu

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

In approximately one-third of patients with sepsis, the source of infection is the urinary tract. The management of sepsis has rapidly changed over the past two decades, and a review of urosepsis management is paramount. It is estimated that in 30% of patients with severe sepsis and septic shock, the underlying reason is a urinary tract infection (UTI). The prevalence of microbiologically proven urosepsis in urology departments has been reported as 1.5% (quarter of health care associated UTIs). On a global level, it has been postulated that 5.4 million deaths occur due to sepsis. The main causes of urosepsis are indwelling urinary catheters and urologic interventions (stone treatment, prostate biopsies, and endoscopic urethral stricture treatment). Urosepsis-causative pathogens are primarily gram-negative bacteria; this is different from sepsis overall, which is dominated by gram-positive bacteria. Its been reported that the resistance rates of pathogens in urosepsis are >10% for almost all antibiotics. The main principles of management of urosepsis and sepsis are the same, including early goal-directed treatment and antibiotic administration within the first 45 min. Early goal-directed therapy was recently shown not to be superior to standard care; however, these results may not be applicable to settings in which standard care needs improvement. Selection of an appropriate antibiotic for the initial empirical treatment in urosepsis requires knowledge of previous interventions, antibiotic usage, and local resistance rates. Future research on the management of urosepsis should be directed toward identification of groups at risk of developing urosepsis, antibiotic selection, and value of biomarkers in treatment response (eg, lactate, procalcitonin).Patient summary: In approximately one-third of patients with sepsis, the source of infection is the urinary tract. This review assessed causes and management of urosepsis and directions for future research. (C) 2016 European Association of Urology. Published by Elsevier B.V. All rights reserved.


Publication metadata

Author(s): Tandogdu Z, Johansen TEB, Bartoletti R, Wagenlehner F

Publication type: Article

Publication status: Published

Journal: European Urology Supplements

Year: 2016

Volume: 15

Issue: 4

Pages: 102-111

Print publication date: 01/07/2016

Online publication date: 28/04/2016

Acceptance date: 02/04/2016

ISSN (print): 1569-9056

ISSN (electronic): 1878-1500

Publisher: Elsevier BV

URL: http://dx.doi.org/10.1016/j.eursup.2016.04.004

DOI: 10.1016/j.eursup.2016.04.004


Altmetrics

Altmetrics provided by Altmetric


Share